Pacira BioSciences, Inc.·4

Dec 18, 6:54 PM ET

McLoughlin Dennis 4

4 · Pacira BioSciences, Inc. · Filed Dec 18, 2019

Insider Transaction Report

Form 4
Period: 2019-12-16
McLoughlin Dennis
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2019-12-16$45.79/sh3,671$168,10816,116 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.73 to $45.81, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]Includes 365 shares of common stock acquired under the issuer's employee stock purchase plan in June 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION